AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Maxygen to Present at the Cowen & Co. 26th Annual Health Care Conference and the Lehman Brothers Ninth Annual Global Healthcare Conference.

PR Newswire

| March 01, 2006 | COPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

REDWOOD CITY, Calif., March 1 /PRNewswire-FirstCall/ -- Maxygen, Inc. today announced that Russell Howard, Ph.D., Maxygen's chief executive officer, will present a corporate overview at the Cowen & Co. Health Care Conference on Tuesday, March 7th at 4:00 p.m. ET at the Boston Marriott Copley Place and at the Lehman Brothers Ninth Annual Healthcare Conference on Wednesday, March 8th at 4:15 p.m. at the Loews Miami Beach Hotel. Both presentations will be webcast and can be accessed by visiting the investor relations section of Maxygen's website at http://www.maxygen.com/.

The presentations will include discussion of non-GAAP financial measures. Reconciliation of the ...

Related articles from newspapers, magazines, journals, and more
Maxygen, Inc. Announces Webcast of Corporate Presentation at the Lehman...
Press release article from: PR Newswire March 28, 2005 700+ words
...PRNewswire-FirstCall/ -- Maxygen, Inc. announced today that the company will present at the Lehman Brothers Eighth Annual Global Healthcare...website at http://www.maxygen.com/. The webcast will...following the presentation. Maxygen, Inc., headquartered in...
Maxygen and Rentschler Sign Agreement to Manufacture Novel G-CSF.
Press release article from: PR Newswire September 9, 2004 700+ words
Maxygen, Inc. and Rentschler Biotechnologie GmbH...Phase I and Phase II clinical supplies of Maxygen's next-generation granulocyte cell stimulating factor (G-CSF) molecule. Maxygen has developed a next-generation G-CSF...
Maxygen and Biovitrum Sign Agreement to Manufacture Optimized Beta Interferon...
Press release article from: PR Newswire June 8, 2004 700+ words
Maxygen, Inc. and Biovitrum AB today announced...of an agreement for the manufacture of Maxygen's improved interferon beta material for...Vice President Business Development of Maxygen. "The manufacturing of our improved interferon...
Maxygen Subsidiary Verdia to be Acquired by DuPont - Final.
News wire article from: The America's Intelligence Wire June 3, 2004 700+ words
...am, you may begin. JANINE MADUROS, IR, MAXYGEN: Good morning, and welcome to the Maxygen conference call to discuss the planned acquisition...uncertainties, including those related to Maxygen's research and business prospects, use of...
Maxygen Creates Novel Protein Activity for New Market Opportunities.
Press release article from: PR Newswire September 18, 2001 700+ words
...Calif., Sept. 18 /PRNewswire/ -- Maxygen, Inc. (Nasdaq: MAXY) has published...market opportunities. The enzymes that Maxygen has created have a range of novel activities...pharmaceutical, chemical and agriculture markets. Maxygen has previously reported numerous examples...
Maxygen Announces Follow-On Bioprocess Collaboration With Pfizer And...
Press release article from: PR Newswire September 13, 2000 700+ words
...Calif., Sept. 13 /PRNewswire/ -- Maxygen (Nasdaq: MAXY) announced today the...manufacturing. In the May 1998 agreement, Maxygen used its proprietary MolecularBreeding...to for the process already improved by Maxygen, with success earning Maxygen research...
Maxygen to Receive $17.8 Million From Acquisition of Avidia by Amgen.
Press release article from: PR Newswire October 27, 2006 700+ words
Maxygen Retains Exclusive Rights to Avidia Technology...Oct. 27 /PRNewswire-FirstCall/ -- Maxygen, Inc. today announced that it expects...development of Avidia's IL-6 product, Maxygen may receive up to an additional $2.8...
Maxygen Announces New Development Program and Product Development...
Press release article from: PR Newswire December 4, 2004 700+ words
Maxygen, Inc. announced today that it will advance...development of its interferon beta program. Maxygen has generated a novel factor VIIa (MAXY...blood loss in relevant preclinical models. Maxygen believes its MAXY-VII product candidate...
Maxygen Announces Joint Venture with Astellas to Develop Protein...
Press release article from: Business Wire June 30, 2009 700+ words
-Maxygen to Contribute R&D Operations and Assets to...Granted 3-Year Option to Acquire Joint Venture- -Maxygen Plans Strategic Restructuring of Remaining Operations- -Maxygen to Host Conference Call on July 1, 2009 at 4:30...
Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur.
Press release article from: PR Newswire December 4, 2007 700+ words
...Dec. 4 /PRNewswire-FirstCall/ -- Maxygen, Inc. , a biotechnology company focused...Group. Under the terms of the agreement, Maxygen will transfer to sanofi pasteur a portfolio...to royalties, total event payments to Maxygen, including an upfront fee, could total...
For more facts and information, see all results

Source: HighBeam Research, Maxygen to Present at the Cowen & Co. 26th Annual Health Care...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA